According to an example aspect of the present invention, there is provided a depot suitable for sustained-release drug delivery, said depot comprising a composite body comprising particles having at least one encapsulated active pharmaceutical ingredient The depot comprises 50 to 95 wt % of the composite body particles, said composite body particles comprising 0.1 to 80 wt % of active pharmaceutical ingredient, and the active pharmaceutical ingredient is a non-steroidal anti-inflammatory drug.
